Dietary Thiamine Has J-Shaped Association With Cognitive Decline
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Feb. 21, 2024 -- For older individuals, dietary thiamine intake has a J-shaped association with cognitive decline, with an inflection point of 0.68 mg/day, according to a study published online Feb. 20 in General Psychiatry.
Chengzhang Liu, from Anhui Medical University in China, and colleagues examined the association between dietary thiamine intake and cognitive decline in 3,106 cognitively healthy, older Chinese individuals. Dietary nutrient intake information was collected through three-day dietary recalls and using a three-day food-weighed method.
Participants were followed for a median of 5.9 years. The researchers identified a J-shaped relationship between dietary thiamine intake and the five-year decline rate in global and composite cognitive scores, with an inflection point of 0.68 mg/day; minimal risk was seen at 0.60 to 1.00 mg/day of dietary thiamine intake. No significant association was seen for thiamine intake before the inflection point with cognitive decline. Each unit increase in thiamine intake beyond the inflection point was associated with significant decreases of 4.24 points in the global score and 0.49 standard units in the composite score within five years. In those with hypertension and/or obesity and in nonsmokers, a stronger positive association between thiamine intake and cognitive decline was seen.
"If substantiated by further research, our study highlights the importance of maintaining optimal dietary thiamine intake levels in the general older population to prevent cognitive decline," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
Multivitamin Use Not Linked to Mortality Benefit in U.S. Adults
WEDNESDAY, June 26, 2024 -- Multivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online June 26 in JAMA Network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.